Skip to content
Unrated Medical device recall · FDA · Published March 10, 2020

Northgate Probe Recall: Biocompatibility Test Failure Risk

Northgate Technologies recalls Probe (NTI Catalog 9-900-54) due to failed biocompatibility testing. Affected units may pose health risks from improper material use in medical procedures.

🇺🇸 FDA recall #Z-1883-2020Medical deviceNorthgate Technologies ›
Take action

Contact the company

Recalling firmNorthgate Technologies, Inc.1591 Scottsdale Ct · Elgin, IL 60123-9361
✎ GovInfoNow plain-language explainer

What happened, in plain English

Northgate Technologies is recalling a medical probe model 9-900-54 because it failed biocompatibility testing. This means the probe could cause health issues if used in medical procedures involving urinary or renal systems. Read more at govinfonow.com/recall/65670-northgate-probe-recall-biocompatibility-test-failure-risk.

Source Summary by GovInfoNow · govinfonow.com/recall/65670-northgate-probe-recall-biocompatibility-test-failure-risk · Updated August 19, 2026 · FDA enforcement record: FDA #Z-1883-2020

Cite this page

“Northgate Probe Recall: Biocompatibility Test Failure Risk.” GovInfoNow, updated August 19, 2026. https://govinfonow.com/recall/65670-northgate-probe-recall-biocompatibility-test-failure-risk. Based on FDA recall #Z-1883-2020 (https://api.fda.gov/device/enforcement.json?search=recall_number:%22Z-1883-2020%22&limit=1).

Why it’s dangerous

The probe failed biocompatibility testing, meaning it may not be safe for medical use. This could lead to health issues if the probe comes into contact with bodily tissues during procedures.

Who’s affected

Medical professionals who use this probe for urinary/renal or biliary procedures are likely affected. Patients receiving these procedures with the recalled probe are at risk.

How to tell if you have this one

Check for the NTI Catalog Number 9-900-54 on the probe. This product is used for fragmenting urinary/renal and biliary calculi in medical procedures.

  • Brand
    Northgate Technologies
  • Category
    Medical device
FDA recall event · 3 products

All 3 products in this recall

FDA lists each product line separately under one recall event. Check your product description, lot or code numbers against each row. Every row shares the hazard and remedy on this page.

  • Classification
    Class II
  • Status
    Terminated
  • Distribution
    US Nationwide distribution. No governmental.
Recall numberProduct, codes & lotsQuantity
Z-1883-2020Probe, 9 FR AUTOLITH; NTI Catalog Number 9-900-54 - Product Usage: Probes are used for the fragmentation of urinary/renal and biliary calculi.; NTI Catalog Number 9-900-54.298 boxes. 3 units per box
Z-1884-2020AUTOLITH URO-TCH 9FR PROBE 54CM; NTI Catalog Number 9-203-0543 - Product Usage: Probes are used for the fragmentation of urinary/renal and biliary calculi.; NTI Catalog Number 9-203-0543.198 boxes. 3 units per box.
Z-1885-2020ACMI 9FR PROBE (E4-9F) Manufactured for Olympus Surgical Technologies, America (OSTA); NTI Catalog Number 72-00198-0 - Product Usage: Probes are used for the fragmentation of urinary/renal and biliary calculi.; NTI Catalog Number 72-00198-0.1238 boxes. 3 units per box.
Based on the official FDA remedy

What to do — step by step

  1. Check Product Details

    Look for the NTI Catalog Number 9-900-54 on the probe to confirm if it is affected.

Where it went and when

Where it was distributed

Distributed nationwide.

Alaska: yesAKMaine: yesMEVermont: yesVTNew Hampshire: yesNHWashington: yesWAIdaho: yesIDMontana: yesMTNorth Dakota: yesNDMinnesota: yesMNIllinois: yesILWisconsin: yesWIMichigan: yesMINew York: yesNYRhode Island: yesRIMassachusetts: yesMAOregon: yesORNevada: yesNVWyoming: yesWYSouth Dakota: yesSDIowa: yesIAIndiana: yesINOhio: yesOHPennsylvania: yesPANew Jersey: yesNJConnecticut: yesCTCalifornia: yesCAUtah: yesUTColorado: yesCONebraska: yesNEMissouri: yesMOKentucky: yesKYWest Virginia: yesWVVirginia: yesVAMaryland: yesMDDelaware: yesDEArizona: yesAZNew Mexico: yesNMKansas: yesKSArkansas: yesARTennessee: yesTNNorth Carolina: yesNCSouth Carolina: yesSCDistrict of Columbia: yesDCOklahoma: yesOKLouisiana: yesLAMississippi: yesMSAlabama: yesALGeorgia: yesGAHawaii: yesHITexas: yesTXFlorida: yesFL

FDA distribution: “US Nationwide distribution. No governmental.” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide.

Recall timeline

FDA terminated this recall 11 months after the firm started it.

1. Firm started the recall: Mar 10, 202012. FDA classified it Class II: May 4, 202023. Published in FDA’s Enforcement Report: May 13, 202034. FDA terminated the recall: Feb 2, 2021420202021
  1. Firm started the recall
  2. FDA classified it Class II
  3. Published in FDA’s Enforcement Report
  4. FDA terminated the recall

Dates from the agency record only; steps without a date are left out.

Similar recalls

Latest medical device recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #Z-1883-2020 (March 10, 2020) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for Z-1883-2020 to see it in context.
  • Plain-language summary written by qwen3:4b on August 19, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA